CS logo
small CS logo
Klinikum Kulmbach

Kulmbach, Germany
General hospital in Kulmbach, Bavaria
Albert-Schweitzer-Straße 10, 95326 Kulmbach

About Klinikum Kulmbach


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
AGO Research GmbH
1
European Breast Cancer Reseach Association of Surgical Trialists
1
Grupo Español de Investigación en Cáncer de Ovario
1
Institut fuer Frauengesundheit
1
Klinikum Coburg
1
Pfizer
1
Total Rows: 6

Clinical Trials at Klinikum Kulmbach


During the past decade, Klinikum Kulmbach conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11002200110000000000Started TrialsCompleted Trails201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Klinikum Kulmbach" #1 sponsor was "AGO Research GmbH" with 1 trials, followed by "European Breast Cancer Reseach Association of Surgical Trialists" with 1 trials sponsored, "Grupo Español de Investigación en Cáncer de Ovario" with 1 trials sponsored, "Institut fuer Frauengesundheit" with 1 trials sponsored and "Klinikum Coburg" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Kulmbach" #1 collaborator was "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "AGO Breast Study Group e.V." with 1 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator, "AGO-B" with 1 trials as a collaborator and "AWOgyn" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAGO Research GmbH: 1AGO Research GmbH: 1European BreastCancer ReseachAssociation of SurgicalTrialists: 1European BreastCancer ReseachAssociation of SurgicalTrialists: 1Grupo Español deInvestigación en Cáncerde Ovario: 1Grupo Español deInvestigación en Cáncerde Ovario: 1Institut fuer Frauengesundheit: 1Institut fuer Frauengesundheit: 1Klinikum Coburg: 1Klinikum Coburg: 1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top CollaboratorsARCAGY/ GINECO GROUP: 2ARCAGY/ GINECO GROUP: 2AGO Breast Study Group e.V.: 1AGO Breast Study Group e.V.: 1AGO Study Group: 1AGO Study Group: 1AGO-B: 1AGO-B: 1AWOgyn: 1AWOgyn: 1ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 1ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 1Australia New ZealandGynaecologicalOncology Group: 1Australia New ZealandGynaecologicalOncology Group: 1Belgian GynaecologicalOncology Group: 1Belgian GynaecologicalOncology Group: 1Claudia von SchillingFoundation for BreastCancer Research: 1Claudia von SchillingFoundation for BreastCancer Research: 1German Breast Group: 1German Breast Group: 1

Clinical Trials Conditions at Klinikum Kulmbach


According to Clinical.Site data, the most researched conditions in "Klinikum Kulmbach" are "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Advanced Breast Cancer" (1 trials), "Breast Cancer Female" (1 trials) and "Breast Neoplasm Female" (1 trials). Many other conditions were trialed in "Klinikum Kulmbach" in a lesser frequency.

Clinical Trials Intervention Types at Klinikum Kulmbach


Most popular intervention types in "Klinikum Kulmbach" are "Drug" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Gemcitabine" (1 trials) and "Niraparib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klinikum Kulmbach


The vast majority of trials in "Klinikum Kulmbach" are 3 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at Klinikum Kulmbach


Currently, there are NaN active trials in "Klinikum Kulmbach". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinikum Kulmbach, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Kulmbach, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2Phase 2: 1Phase 2: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 3Recruiting: 3Active, not recruiting: 1Active, not recruiting: 1Completed: 1Completed: 1Unknown status: 1Unknown status: 1